Susquehanna International Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-37,100
| Closed | -$110K | – | 14329 |
|
|
2022
Q1 | $110K | Sell |
37,100
-31,200
| -46% | -$117K | ﹤0.01% | 11841 |
|
|
2021
Q4 | $307K | Sell |
68,300
-115,100
| -63% | -$546K | ﹤0.01% | 10453 |
|
|
2021
Q3 | $891K | Buy |
183,400
+90,400
| +97% | +$498K | ﹤0.01% | 7873 |
|
|
2021
Q2 | $634K | Buy |
93,000
+40,000
| +75% | +$323K | ﹤0.01% | 8987 |
|
|
2021
Q1 | $374K | Sell |
53,000
-57,300
| -52% | -$413K | ﹤0.01% | 10136 |
|
|
2020
Q4 | $690K | Buy |
110,300
+62,000
| +128% | +$365K | ﹤0.01% | 7581 |
|
|
2020
Q3 | $261K | Buy |
48,300
+14,000
| +41% | +$69.3K | ﹤0.01% | 8982 |
|
|
2020
Q2 | $179K | Sell |
34,300
-15,800
| -32% | -$70.2K | ﹤0.01% | 9134 |
|
|
2020
Q1 | $158K | Sell |
50,100
-24,400
| -33% | -$90K | ﹤0.01% | 8946 |
|
|
2019
Q4 | $300K | Buy |
74,500
+35,600
| +92% | +$124K | ﹤0.01% | 8022 |
|
|
2019
Q3 | $168K | Buy |
+38,900
| New | +$156K | ﹤0.01% | 9244 |
|
|
2019
Q2 | – | Sell |
-14,200
| Closed | -$76K | – | 11014 |
|
|
2019
Q1 | $76K | Sell |
14,200
-6,300
| -31% | -$40.7K | ﹤0.01% | 8350 |
|
|
2018
Q4 | $105K | Sell |
20,500
-26,800
| -57% | -$203K | ﹤0.01% | 8199 |
|
|
2018
Q3 | $459K | Sell |
47,300
-24,800
| -34% | -$250K | ﹤0.01% | 6696 |
|
|
2018
Q2 | $735K | Sell |
72,100
-2,700
| -4% | -$30.6K | ﹤0.01% | 6038 |
|
|
2018
Q1 | $972K | Buy |
74,800
+4,600
| +7% | +$68.5K | ﹤0.01% | 5304 |
|
|
2017
Q4 | $1.26M | Sell |
70,200
-22,500
| -24% | -$469K | ﹤0.01% | 4776 |
|
|
2017
Q3 | $2.33M | Buy |
92,700
+900
| +1% | +$20.9K | ﹤0.01% | 3635 |
|
|
2017
Q2 | $2.21M | Buy |
91,800
+55,000
| +149% | +$1.22M | ﹤0.01% | 3742 |
|
|
2017
Q1 | $708K | Buy |
+36,800
| New | +$580K | ﹤0.01% | 5846 |
|
|
2016
Q3 | – | Sell |
-12,100
| Closed | -$168K | – | 9217 |
|
|
2016
Q2 | $168K | Buy |
+12,100
| New | +$178K | ﹤0.01% | 7747 |
|
|
2013
Q3 | – | Sell |
-3,992
| Closed | -$145K | – | 8873 |
|
|
2013
Q2 | $145K | Buy |
+3,992
| New | +$171K | ﹤0.01% | 7651 |
|
Susquehanna International Group's PRTK Position: Q3 2023 in Review
Susquehanna International Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 118,025 shares — an estimated $261K sold.
Susquehanna International Group first reported a position in PRTK in Q2 2013 and held it in 32 quarters. The position peaked at $2.24M in Q4 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Susquehanna International Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 118,025 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $261K.
- Susquehanna International Group first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 32 quarters.
- Susquehanna International Group's Paratek Pharmaceuticals, Inc. position peaked at $2.24M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.